Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Triple receptor profile GLP-1R, GIPR, and GCGR simultaneous engagement in research models Referenced in peer-reviewed literature on triple incretin receptor pharmacology Useful for comparative studies alongside single and dual agonist reference compounds Lyophilized format ensures stability and reproducibility across experimental runs Batch and lot identifiers on all labeling for full laboratory documentation compliance Research Background GLP3-R (Retatrutide) has been referenced in scientific literature as a GLP-1/GIP/glucagon receptor triple agonist
Dipeptidyl-peptidase IV (CD26) role in the inactivation of regulatory peptides
Free radicals cause "oxidative stress," which damages cell structures and accelerates aging
Commenting on the patient safety alert, Douglas Twenefour, head of care at Diabetes UK, said: The ongoing shortages of GLP-1 medications are having serious implications for many people with T2DM and are still a major concern
US$ 28.64
US$ 20.72
US$ 26.52
US$ 21.90
US$ 24.37
US$ 20.71
:max_bytes(150000):strip_icc()/Health-GettyImages-2177990872-3ef7dc37a7904ccb9ef456f494bc6348.jpg)
